Decades of research have looked into the exact mechanisms of how acupuncture effectively reduces chronic pain. Initial animal research discovered the release of endogenous opioids within the central nervous system following electroacupuncture. This release of the body's own opioids allows for greater activation of the top-down inhibition of pain. Other brain imaging research found acupuncture is able to modulate the activity in multiple structures of the brain that make up the pain network.
Now, yet another mechanism of action is under the microscope: the endocannabinoid system. New research is suggesting Pc 6 may be the "CBD" of acupuncture.
Understanding The Endocannabinoid System
With the increasing popularity of CBD products now available on the market and the legalization of THC compounds in many areas, an explosion of research has been published of late on the endocannabinoid system in the brain. Let's discuss a specific pathway in the top-down modulation of pain and inflammation involving the hypothalamus, the periaqueductal grey (PAG) in the midbrain, and the rostral ventral medulla (RVM) in the lower brainstem.
The brain produces its own endocannabinoids, with 2-Arachidonoylglycerol (2-AG) being one of them. The production of 2-AG depends upon a very special neuropeptide called orexin A. orexin A is released only by orexin neurons. These orexin-expressing neurons originate in the hypothalamus and project to many areas of the brain including the PAG and the RVM.
After orexin A signals the production of 2-AG, 2-AG is then able to bind to the cannabinoid 1 receptors (CB1R) that are found in the PAG. This results in modulation of activity in the RVM and engages the top-down inhibition of pain.
What Does This Have to Do With Acupuncture?
Electroacupuncture at Pc 6 (2 Hz mA for 20 minutes) was shown in animal research studies to activate orexin neurons in the hypothalamus and increase the release of orexin A in the PAG. This activated the production of 2-AG and increased activity of the endocannabinoid system that fires from the PAG to the RVM to the dorsal horn in the spinal cord. The end result is that pain is inhibited via a unique and independent pathway involving the endocannabinoid system.
In order to look at this pain-inhibiting mechanism independently of the endogenous opioid system, the researchers used a common antagonist of the opioid receptors. Naloxone is a compound that blocks the effects of beta-endorphins and has been commonly used in research on Li 4.
Li 4 causes a strong release of endogenous opioids to achieve an inhibitory effect on pain. However, when naloxone is introduced into the system and blocks the opiate receptors, the effects of Li 4 on pain inhibition are reduced.
The research on Pc 6 found that naloxone did not block its pain-inhibiting effects, because Pc 6 was acting through a different mechanism, the endocannabinoid mechanism, independent of endogenous opioids. The investigators took their research a step further and used an orexin antagonist, a compound that specifically blocks that activity of orexins at the PAG. When the activity of orexin A was blocked, the pain-inhibition actions of Pc 6 were also blocked.
While we have to interpret animal research with caution, this research mirrors the procedures and process of the decades of research that led to our understanding of the effects of acupuncture on the endogenous opiate system.
Relevance to Clinical Acupuncture Practice
Patients who have developed opiate dependence and opiate tolerance can benefit from the activation of an alternative mechanism of pain inhibition through the use of electroacupuncture at Pc 6. Pairing electroacupuncture at Li 4 and Pc 6 can activate both the endogenous opiate system and the endocannabinoid system for an even stronger central nervous system effect on treating chronic pain.
Resources
Do you receive text messages from companies letting you know about offers or giveaways, or simply sharing news? If your answer is yes, then you have opted in for SMS (short message service) text-message marketing. SMS text-message marketing uses various platforms and software to send personalized, timely and sometimes interactive messages.
The Oregon College of Oriental Medicine (OCOM) has announced it is closing after 41 years. Pending accreditor approval, OCOM will cease offering classes after September (fourth-year OCOM students graduate Aug. 26). All current / incoming OCOM students have the option of continuing their education at the National University of Natural Medicine or Five Branches University, or transferring to another school altogether.
| Digital Exclusive
The end of cancer treatment does not necessarily signal a return to good health. Cancer survivors report poorer health and well-being than people who have not had cancer; many suffer chronic consequences of cancer and its treatments. Some may also develop new symptoms many years after treatment has ended.
